pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    linvoseltamab
    Lynozyfic (linvoseltamab)
    Refractory Multiple Myeloma$REGN REGENERON PHARMACEUTICALS, INC.
  • pre_registration
    lirafugratinib hydrochloride
    lirafugratinib hydrochloride
    Bile Duct Cancer (Cholangiocarcinoma) Elevar Therapeutics Inc
  • Phase 1
    liraltagene autoleucel
    liraltagene autoleucel
    Epithelial Ovarian Cancer$ANIX Anixa Biosciences Inc
← prev
page 50 of 62
next →
Pain89
Neurology1
Phase 3
lisaftoclax
lisaftoclax [INN]
Myelodysplastic Syndrome (Preleukemia)
$AAPG ASCENTAGE PHARMA GROUP INTERNATIONAL
  • Phase 2
    lisocabtagene maraleucel
    Breyanzi (lisocabtagene maraleucel)
    Chronic Lymphocytic Leukemia (CLL) Bristol-Myers Squibb Co
  • Phase 2
    lixadesiran + pixofisiran
    lixadesiran [INN] + pixofisiran [INN]
    Basal Cell Carcinoma (Basal Cell Epithelioma) Sirnaomics Ltd
  • Phase 1
    lixumistat
    lixumistat [INN]
    Pancreatic Ductal Adenocarcinoma Immunomet Therapeutics Inc
  • Phase 1
    lomonitinib
    lomonitinib [INN]
    Refractory Acute Myeloid Leukemia Lomond Therapeutics Holdings Inc
  • Phase 1
    lonitoclax
    lonitoclax [INN]
    Marginal Zone B-Cell Lymphoma Lomond Therapeutics Holdings Inc
  • Phase 2
    lorigerlimab
    lorigerlimab
    Colorectal Cancer$MGNX MACROGENICS INC
  • Phase 2
    lucicebtide
    lucicebtide
    Esophageal Cancer Sapience Therapeutics Inc
  • Phase 2
    ludotadipep
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) FutureChem Co Ltd
  • Phase 2
    lunbotinib
    lunbotinib [INN]
    Non-Small Cell Lung Cancer Ellipses Pharma Ltd
  • Phase 3
    lutadenovec autogene + sapecmeran autogene
    lutadenovec autogene + sapecmeran autogene
    Metastatic Colorectal Cancer Nexoplex Bio LLC
  • Phase 3
    lutetium (177Lu) rosopatamab tetraxetan
    lutetium (177Lu) rosopatamab tetraxetan [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$TLX Telix Pharmaceuticals Ltd
  • Phase 3
    lutetium (177Lu) zadavotide guraxetan
    lutetium (177Lu) zadavotide guraxetan
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Curium Midco Sarl
  • Marketed
    lutetium Lu 177 dotatate
    Lutathera (lutetium Lu 177 dotatate)
    Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Advanced Accelerator Applications SA
  • pre_registration
    lutetium Lu 177 edotreotide
    lutetium Lu 177 edotreotide
    Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) ITM Isotope Technologies Munich SE
  • Phase 2
    luvixasertib
    luvixasertib [INN]
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Treadwell Therapeutics Inc
  • Phase 1
    mRNA-4106
    Cervical Cancer$MRNA Moderna, Inc.
  • Phase 2
    mRNA-4359
    Solid Tumor$MRNA Moderna, Inc.
  • Preclinical
    magnesium lysinate bis eicosapentaenoate
    magnesium lysinate bis eicosapentaenoate
    Pancreatic Cancer Thetis Pharmaceuticals LLC
  • Phase 2
    margetuximab
    Margenza (margetuximab-cmkb)
    Gastric Cancer TerSera Therapeutics LLC
  • Phase 3
    masitinib
    masitinib [INN]
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) AB Science SA
  • Phase 2
    maveropepimut-s
    maveropepimut-s
    Fallopian Tube Cancer$BVAXF BioVaxys Technology Corp.
  • Phase 2
    mavrostobart
    mavrostobart
    Solid Tumor Phanes Therapeutics Inc
  • Phase 2
    mecbotamab vedotin
    mecbotamab vedotin
    Non-Small Cell Lung Cancer$BCAB BioAtla, Inc.
  • Marketed
    mechlorethamine hydrochloride
    Valchlor (mechlorethamine hydrochloride)
    Mycosis Fungoides Helsinn Therapeutics (US) Inc
  • Marketed
    megestrol acetate
    Megestrol Acetate
    Anorexia Nervosa TWi Pharmaceuticals USA Inc
  • Marketed
    melphalan
    Evomela (melphalan)
    Retinoblastoma Zhaoke Ophthalmology Ltd